TTS Pharma Ltd
About us
Management
Board of Directors
Advisors
History
Values
Legal compliance
Products
CBD for Cosmetics
CBD for Food Supplements
R&D
Events
News
Contact
News
For media enquiries, please contact our press office :
ttspharma@sciad.com
Press and Media
Top 10 European Cannabis Tech Startups to Watch Out in 2020 – IndustryWired
, July 2020
CBD and transparency: Not all CBDs are the same
– Cosmetics Business, June 2020
Can you afford to ignore the CBD Market?
– P3 Pharmacy, March 2020
CBD Trending ingredient or ingredient trend
? – Food Navigator.com, January 2020
The Global Cannabinoid Pharmaceutical Industry –
European Pharmaceutical Review, December 2019
What does legal limbo mean for CBD – Food Navigator.com, December 2019
TTS Pharma tests reveal labelling issues amongst CBD products
– Nutraingredients.com, October 2019
CBD the science behind purity –
European Pharmaceutical Review (EPR), September 2019
An “unrestrained” market? Survey highlights “illegal and unsafe” CBD products on UK market
– Nutrition Insight, September 2019
Analysis shows THC and contaminants rife in UK CBD products – The Leaf Desk
, September 2019
Research Commercial cannabidiol on the UK market is illegal
-Cleanroom Technology, September 2019
Research Commercial cannabidiol on the UK market is illegal
– Manufacturing Chemist, September 2019
Research Commercial cannabidiol on the UK market is illegal
– Nutraceutical Business Review, September 2019
Patience Wins The Race
– Pharma Intelligence, September 2019
Actuality
CBD Products – Safety Data & Novel Foods Application
TTS Pharma have formed the first Primary Authority (PA) partnership in the United Kingdom for CBD products.
TTS Pharma is the first UK manufacturer to produce commercial cannabidiol free of illegal THC and CBN
TTS Pharma Limited – Announces closing of £10.3 million fundraising and new board appointment
